日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Strain-level metagenomic profiling using pangenome graphs with PanTax

利用 PanTax 和泛基因组图进行菌株水平宏基因组分析

Zhang, Wenhai; Liu, Yuansheng; Li, Guangyi; Xu, Jialu; Chen, Enlian; Schönhuth, Alexander; Luo, Xiao

Rapid Authentication of Flowers of Panax ginseng and Panax notoginseng Using High-Resolution Melting (HRM) Analysis

利用高分辨率熔解曲线(HRM)分析快速鉴别人参和三七花

Wang, Menghu; Li, Wenpei; Zuo, Yafeng; Jiang, Qianqian; Li, Jincai; Zhang, Wenhai; Meng, Xiangsong

Survival benefit of neoadjuvant chemotherapy in HR+/HER2- early breast cancer stratified by luminal B status and clinical risk: a real-world cohort study in a Chinese population

新辅助化疗对HR+/HER2-早期乳腺癌患者的生存获益:基于Luminal B分型和临床风险分层的中国人群真实世界队列研究

Wang, Wei; Liang, Xueyan; Yang, Yuchao; Zhang, Wenhai; Huang, Denghua; Li, Jiajun; Liu, Yukun; Ren, Hui

Ultra-rapid preparation of large-area high-crystallinity covalent organic framework membranes

超快速制备大面积高结晶度共价有机框架膜

Pan, Yan; Yu, Gangqiang; Gao, Luteng; Li, Xueyong; Yang, Lan; Gao, Haiqi; Wang, Tianfu; Zhang, Wenhai; Ma, Shengqian; Meng, Hong

Manipulating Surface Chemistry on the Microarchitecture of Coal-Based Hard Carbon for Improved Sodium Storage

通过调控煤基硬碳微结构的表面化学性质来提高其钠存储性能

Zhang, Wenhai; Song, Ruizhen; Meng, Hong; Tang, Yakun; Zhang, Yue; Liu, Lang; Han, Ping; Deng, Limin; Cao, Yuliang

Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with MTAP Deletion

TNG462 的发现:一种高效且选择性强的 MTA 协同 PRMT5 抑制剂,可靶向治疗 MTAP 缺失的癌症

Kevin M Cottrell,Kimberly J Briggs,Alice Tsai,Matthew R Tonini,Douglas A Whittington,Shanzhong Gong,Colin Liang,Patrick McCarren,Minjie Zhang,Wenhai Zhang,Alan Huang,John P Maxwell

Novel nanobody-161 binds tumor necrosis factor receptor 2 (TNFR2) to exert an anti-tumor effect but does not block TNFα-binding.

新型纳米抗体-161 与肿瘤坏死因子受体 2 (TNFR2) 结合,发挥抗肿瘤作用,但不阻断 TNFα 结合。

Huang Liang, Kong Chao, Hu Yuhao, Zhang Michael, Li Shuangqi, Wang Wanjing, Guan Hui, Lim Mei Ling, Zhang Zhen, Zhang Wenhai, Zheng Hailiang, Yan Xintian, Sun Xinglu, Lei Pan, Dai Shanshan, Wang Wenrong, Lu Linlin, Zhou Junma, Fan Shilong, Lang Guojun

Characterization of TNG348: A Selective, Allosteric USP1 Inhibitor That Synergizes with PARP Inhibitors in Tumors with Homologous Recombination Deficiency.

TNG348 的特性:一种选择性变构 USP1 抑制剂,可与 PARP 抑制剂在同源重组缺陷肿瘤中发挥协同作用

Simoneau Antoine, Pratt Charlotte B, Wu Hsin-Jung, Rajeswaran Shreya S, Comer Charlotte Grace, Sudsakorn Sirimas, Zhang Wenhai, Liu Shangtao, Meier Samuel R, Choi Ashley H, Khendu Tenzing, Stowe Hannah, Shen Binzhang, Whittington Douglas A, Chen Yingnan, Yu Yi, Mallender William D, Feng Tianshu, Andersen Jannik N, Maxwell John P, Throner Scott

TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers

TNG908 是一种可穿透血脑屏障的 MTA 协同 PRMT5 抑制剂,专为治疗 MTAP 缺失型癌症而开发。

Briggs, Kimberly J; Cottrell, Kevin M; Tonini, Matthew R; Tsai, Alice; Zhang, Minjie; Whittington, Douglas A; Zhang, Wenhai; Lombardo, Steven A; Yoda, Satoshi; Wilker, Erik W; Meier, Samuel R; Yu, Yi; Teng, Teng; Huang, Alan; Maxwell, John P

Association of neutrophil percentage-to-albumin ratio with distant metastasis and survival outcomes in breast cancer patients: a retrospective and prospective cohort study

中性粒细胞百分比与白蛋白比值与乳腺癌患者远处转移和生存结局的关系:一项回顾性和前瞻性队列研究

Liu, Yukun; Luo, Rui; Wu, Ziying; Zhang, Wenhai; Liang, Chunfeng; Liu, Zihao; Zhao, Hui